These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35929565)
1. First report of auxiliary liver transplantation for severe cholangiopathy after SARS-CoV-2 respiratory infection. Rela M; Rajakannu M; Veerankutty FH; Vij M; Rammohan A Am J Transplant; 2022 Dec; 22(12):3143-3145. PubMed ID: 35929565 [TBL] [Abstract][Full Text] [Related]
2. Is post COVID-19 cholangiopathy an appropriate indication for liver transplantation? Kiyak M; Ayhan R; Yavuz M; Demirtas C; Çakmak S; Altunöz E; İpek S Rev Esp Enferm Dig; 2024 Jun; 116(6):336-337. PubMed ID: 37314132 [TBL] [Abstract][Full Text] [Related]
3. Liver transplantation for post-COVID-19 cholangiopathy: A case series. Sambommatsu Y; Mouch C; Kulkarni AV; Bruno DA; Eslami M; Imai D; Lee SD; Khan AA; Sharma A; Saeed M; Cotterell AH; Levy MF; Morales MK; Montenovo MI; Rao PN; Reddy R; Menon B; Kumaran V Clin Transplant; 2023 Dec; 37(12):e15141. PubMed ID: 37755152 [TBL] [Abstract][Full Text] [Related]
4. Post-COVID-19 Cholestasis: A Case Series and Review of Literature. Kulkarni AV; Khelgi A; Sekaran A; Reddy R; Sharma M; Tirumalle S; Gora BA; Somireddy A; Reddy J; Menon B; Reddy DN; Rao NP J Clin Exp Hepatol; 2022; 12(6):1580-1590. PubMed ID: 35719861 [TBL] [Abstract][Full Text] [Related]
5. A case of coronavirus disease 2019-infected liver transplant donor. Hong HL; Kim SH; Choi DL; Kwon HH Am J Transplant; 2020 Oct; 20(10):2938-2941. PubMed ID: 32400013 [TBL] [Abstract][Full Text] [Related]
6. The case of a liver-transplant recipient with severe acute respiratory syndrome coronavirus 2 infection who had a favorable outcome. Hayashi K; Ito Y; Yamane R; Yoshizaki M; Matsushita K; Kajikawa G; Kozawa T; Mizutani T; Shimizu Y; Nagano K; Tachi K; Yoshioka K; Goto H Clin J Gastroenterol; 2021 Jun; 14(3):842-845. PubMed ID: 33675512 [TBL] [Abstract][Full Text] [Related]
7. Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report. Durazo FA; Nicholas AA; Mahaffey JJ; Sova S; Evans JJ; Trivella JP; Loy V; Kim J; Zimmerman MA; Hong JC Transplant Proc; 2021 May; 53(4):1132-1137. PubMed ID: 33846012 [TBL] [Abstract][Full Text] [Related]
8. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929 [TBL] [Abstract][Full Text] [Related]
9. Liver transplantation for post-COVID-19 sclerosing cholangitis. Lee A; Wein AN; Doyle MBM; Chapman WC BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34446515 [TBL] [Abstract][Full Text] [Related]
10. Post-COVID-19 cholangiopathy: Current understanding and management options. Veerankutty FH; Sengupta K; Vij M; Rammohan A; Jothimani D; Murali A; Rela M World J Gastrointest Surg; 2023 May; 15(5):788-798. PubMed ID: 37342848 [TBL] [Abstract][Full Text] [Related]
12. Impact of COVID-19 on living donor liver and kidney transplantation programs in Japan in 2020. Kuramitsu K; Yamanaga S; Osawa R; Hibi T; Yoshikawa M; Toyoda M; Shimata K; Yosuke E; Ono M; Kenmochi T; Sogawa H; Natori Y; Yano H; Chen-Yoshikawa T; Yoshida K; Fukumoto T; Yuzawa K; Egawa H Transpl Infect Dis; 2022 Jun; 24(3):e13845. PubMed ID: 35505462 [TBL] [Abstract][Full Text] [Related]
13. A Recipient and Donor Both Have COVID-19 Disease. Should We Perform a Liver Transplant? Tuncer A; Akbulut S; Baskiran A; Karakas EE; Baskiran DY; Carr B; Yilmaz S J Gastrointest Cancer; 2021 Sep; 52(3):1143-1147. PubMed ID: 33599922 [TBL] [Abstract][Full Text] [Related]
14. Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor. Manzia TM; Gazia C; Lenci I; Angelico R; Toti L; Monaco A; Anselmo A; Baiocchi L; Grossi P; Tisone G Am J Transplant; 2021 Jul; 21(7):2600-2604. PubMed ID: 33621393 [TBL] [Abstract][Full Text] [Related]
15. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related]
16. Donor safety in living donor liver transplantation: The Korean organ transplantation registry study. Lee JG; Lee KW; Kwon CHD; Chu CW; Kim BW; Choi DL; You YK; Kim DS; Nah YW; Kang KJ; Choi IS; Yu HC; Hong G; Han HS; Hwang S; Kim MS Liver Transpl; 2017 Aug; 23(8):999-1006. PubMed ID: 28431203 [TBL] [Abstract][Full Text] [Related]
18. Early liver transplantation after COVID-19 infection: The first report. Kulkarni AV; Parthasarathy K; Kumar P; Sharma M; Reddy R; Chaitanya Akkaraju Venkata K; Gupta R; Gupta A; Swaroop S; Giri Vishwanathan P; Senapathy G; Menon PB; Reddy ND; Padaki NR Am J Transplant; 2021 Jun; 21(6):2279-2284. PubMed ID: 33508881 [TBL] [Abstract][Full Text] [Related]
19. Outcome of donors with a remnant liver volume of less than 35% after right hepatectomy. Cho JY; Suh KS; Kwon CH; Yi NJ; Lee HH; Park JW; Lee KW; Joh JW; Lee SK; Lee KU Liver Transpl; 2006 Feb; 12(2):201-6. PubMed ID: 16447201 [TBL] [Abstract][Full Text] [Related]
20. Age-adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID-19 patients. Hartl L; Haslinger K; Angerer M; Jachs M; Simbrunner B; Bauer DJM; Semmler G; Scheiner B; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Trauner M; Mandorfer M; Reiberger T Liver Int; 2022 Jun; 42(6):1297-1307. PubMed ID: 35412018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]